The central idea of ELYNS is to make the scholarly
literature and scientific wisdom free and open to the
scientific as well as the common world.
more

All Special Issues

Celiac Disease and Non-Celiac Gluten Sensitivity


Handling Editor

Dr. Luis Rodrigo, 

University of Oviedo

Dr. Luis Rodrigo received his PhD degree from University of Oviedo in 1975. He is Specialist in Gastroenterology through the National Program of Fellowship in the Clinic “Puerta de Hierro” of Madrid, from January 1967 to December 1971. He published 235 scientific papers in English and 281 papers in Spanish. He had written a total of 58 chapters of books in Gastroenterology and 8 books about “Treatment in gastroenterological diseases”and other digestive and liver diseases. Currently he is Titular Professor in Medicine at the University of Oviedo. 


About the Special Issue

The Journal of Gastroenterology and Hepatobiliary Disorders (ISSN 2470-9891) is currently inviting submissions for a special issue entitled "Celiac Disease and Non-celiac gluten sensitivity”.

Prof. Dr. Luis Rodrigo of the University of Oviedo, Oviedo (Spain), is serving as Guest Editor for this issue.

Recent studies published mainly in the last 15 years, support the existence of a new condition, named as “Non-Celiac Gluten Sensitivity” (NCGS), which manifests as intestinal or extraintestinal symptoms that improve, or completely disappear, after the gluten withdrawal of their diets, and affects to individuals that show normal or minimum changes at the small-bowel mucosa and negative results on serum anti-transglutaminase and antiendomysial antibody testing.

Although the Clinical value of this concept is under debate, the prevalence of NCGS in the general population is supposed to be many times higher than that of celiac disease. The lack of an unambiguous definition of this disease may pose some difficulties and can improve the treatment and prognosis of many patients being classified as “functional” with several different diagnosis of a variety of diseases not only digestive, but also of extraintestinal location.

Based on your expertise in this field, we think you could make an excellent contribution of either evidence-based original research or a review of the scientific literature.

The submission deadline is 31st October 2017.

To check suitability, we encourage authors to send a short abstract or tentative title in advance to the Editorial Office.

For further details on the submission process, please see the instructions for authors at the journal’s website

Keywords:

•          Gluten-related disorders

•          Celiac disease

•          Non-celiac Gluten Sensitivity

•          Gluten intolerance

•          Gluten sensitivity

•          Extra-intestinal manifestations

•          Gluten-free diet

We look forward to hearing from you.

Kindregards,

Prof. Luis Rodrigo MD

Chief Editor of JGHD


Solid Thin Films for Energy Application


Handling Editor

Dr. Faiyaz Shakeel, 

King Saud University, KSA

Dr. Faiyaz Shakeel is working as associate professor King Saud University, Riyadh, Saudi Arabia. He has around 12 years of research experience in the field of Pharmaceutical Sciences. His main area of research includes Nanomedicine, Advanced Drug Delivery Systems, Self-nanoemulsifying Drug Delivery system, Colloidal Drug Carriers, Solubility and Pharmaceutical Analysis etc. He has been honored with several awards like most cited research paper award, best scientific poster award and young scientist award etc.


About the Special Issue

To meet the growing energy demands (which is increasing exponentially), there is an urgent need to improve the overall efficiency of every section of the entire energy generation processes and to minimize the energy loss incurred during energy production. One of the ways to achieve this target was to employ high performance multi-scale advanced coatings on its surface which will result in improved electricity storing capacity in addition to amplified electrochemical performance coatings as well as its operation at higher temperatures. These types of tailored coatings (either thin or thick films) with their desired inherent characteristics can be used for different energy producing processes and systems. In the past decade, thin-film technology has been exploited commercially in batteries, supercapacitors, solar energy system, fuel cells, and electrochromic devices such as smart windows or displays. Certain electro-mechanical properties such as high ionic conductivity, very low electronic conductivity, sufficient chemical as well as mechanical stability of the materials is a must for any solid electrolytes to be used in thin film technology.

The reasons for the failure of many elements of installations operating in the power plant industry (both thermal as well as nuclear power plants) are the combined processes of erosion and corrosion occurring at high temperatures. A method used to protect the areas of intense wear is the application of protective coatings, which assure the required operation durability.

In this issue, advanced coating materials, its fabrication, significance and potential applications will be published for various forms of energy generation and storage about the application of thin films and thick coatings of conventional/nanomaterials in both renewable and non-renewable energy sectors.

Both research as well as review articles will be published in this issue. This special issue will contain high quality papers will be accepted for publication after strict peer review but not limited to, in the following topical subheadings:

  1. Synthesis and Characterization
  2. Surfaces, Interfaces, and Colloidal Behavior
  3. Metallurgical, Protective, and Hard Layers
  4. Mechanics and Nanomechanics of Thin Layers
  5. Electronics, Optics, and Opto-electronics
  6. Magnetics and Magneto-optics
  7. Superconductivity
  8. Langmuir—Blodgett, Biological, and Related Films
  9. Thin Film Devices, Sensors, and Actuators
  10. Condensed Matter Film Behavior

Timeline

Last date for articles submission: 30-09-2017
Last date for peer review process: 30-11-2017
Expected date for final publication: 31-01-2018


Nanomedicine and Stem Cell Therapy


Handling Editor

Dr. Fahima Dilnawaz, 

Institute of Life Sciences, India

Dr Fahima Dilnawaz is working as women scientist in the nanomedicine laboratory at Institute of Life Sciences, Bhubaneswar, Odisha, India. She is actively working in the field of cancer drug delivery especially using magnetic nanoparticles, polymeric nanoparticles and mesoporous silica nanoparticles etc. The development of novel formulation of water dispersible magnetic nanoparticle has been granted patent in India, Australia, Europe and USA. She has published research articles in peer reviewed journals, contributed book chapters and has delivered invited talks in national and international conferences. 


About the Special Issue

Tumours are heterogeneous in nature and they contain tiny populations  of cells known as cancer stem cells (CSCs) that are highly tumorigenic and exhibits distinctive self renewal properties which plays crucial role in intrinsic drug resistant, recurrence and metastasis in multiple malignancies. CSCs often overexpress drug efflux transporters that mostly stay in non-dividing state; as a result it narrowly escapes from the conventional chemotherapies. Recent developments of nanomedicinal approach have made tremendous progress in increased circulation time, ability to carry heavy drugload, enhanced drug accumulation as an attractive treatment option. Apart from that attention has been given to design nanomedicine that would penetrate the CSC niche and would significantly increase the therapeutic drug accumulations which were earlier difficult to reach by overcoming pump-mediated multidrug resistance. In this regard we invite investigators to contribute research as well as review articles that will stimulate to understand and discuss the state-of-the- art of nanomedicine approach that are developed to kill CSCs such as:

  1. Multivarious nanomedicinal therapeutic approach that target the CSCs and prevent cancer relapse addressing the emerging drug resistance issue.
  2. Development of nanoformulations that targets the metabolism of CSC.
  3.  Developments of inhibitors that blocks CSCs surface markers for enhanced specificity of nanomedicinal therapy.
  4. Development of nanoparticles mediated nucleic acid based therapeutic for CSCs.

Timeline

Last date for articles submission: August 30, 2017
Last date for peer review process: October 30, 2017
Expected date for final publication: December 31, 2017


Epidemiology of Violence


Handling Editor

Dr. Samar Ahmed, 

Director of Project Development, External Relations and Copy Rights Center
Director of Residency training Support Office

Dr. Samar Abdel azim Ahmed received her Postdoc in Medical Education at FAIMER institute, Philadelphia in 2012. Currently she is Associate Professor in the department of forensic medicine and toxicology at Ain Shams University, Egypt and vice president of the project for faculty development and accreditation of the faculty of Medicine, Director of international cooperation group Forensic medicine and toxicology department, ASU. She is the Regional coordinator of WAWFE (worldwide Association for Women Forensic Experts), Member of the network TUFH (towards Unity for Health). 


About the Special Issue

The Editorial Board is proud to present this Special Issue Epidemiology of Violence. We are driven to launch this issue by the pressing need of the community to study and exploit findings that would profile violence. In this world of rising violence, a multidisciplinary approach to problem assessment becomes the only sensible approach.

In view of the importance of information sharing, it has become of vast importance that information regarding this specific issue be rendered available and transmittable regardless of geographic boundaries. Nations tend to build on available experiences and in order to be able to tackle violence from a forensic point of view, mapping of the problem needs to be done first. This will help in anticipating the rising problem and in creating future profiles for violence.

In this issue, original research papers will be accepted covering the following topics;

  1. Sociodemographic assessment
  2. Mapping of trends of violence
  3. Study of risk factors related to violence
  4. Forensic psychiatric studies
  5. Criminal profiling
  6. Cold case analysis and
  7. Risk assessment in relation to all types of violence.

Finally, I should add that we are committed to a speedy and rational refereeing process for every piece of scholarship submitted to us. We endeavor to reply to all papers submitted within five weeks time with an answer about acceptance or rejection. We also do not require formatting for submissions in our style until after the paper has been accepted by us for publication.

I’d like to thank our Editorial Board for their work so far in helping to found the JFML. 

Timeline

Last date for articles submission: 30-09-2017

Last date for peer review process: 30-11-2017

Expected date for final publication: 31-01-2018


Inflammatory Basis of Cardiovascular Disease, Cancer and Diabetes


Handling Editor

Dr. David P Hajjar, 

Weill Cornell Medicine, Cornell University

Dr. David P. Hajjar received his Ph.D. in 1978 from the University of New Hampshire. He is currently University Distinguished Professor and Professor of Biochemistry and Pathology at Weill Cornell Medicine at Cornell University in New York City where he has been on the faculty since 1981. He has published over 170 papers in cardiovascular research. He is also Dean Emeritus of the Weill Cornell Graduate School of Medical Sciences in New York. He is a member of the American Academy of Arts and Sciences, and Associate Editor of the Journal of Enzymology and Metabolism. He is the recipient of many scientific awards form the Andrew Mellon Foundation, the American Heart Association and the FASEB society.


About the Special Issue

This special issue was created since cardiovascular diseases (CVD), diabetes, and cancer share commonalities involving metabolic disturbances that reflect dysregulated energy homeostasis and metabolic control. To date, how these processes relate physiologically remains undefined. According to the Centers for Disease Control and Prevention, these diseases can affect most Americans, and a steady increase in disease burden is predicted for the remainder of the 21st century. Changes in metabolic pathways, many of which are influenced by inflammation, are associated with CVD, type 2 diabetes, and cancer.  Although a number of key regulatory molecules including specific receptors have been identified, their utility as therapeutic targets is limited by the multiplicity of intersecting pathways in which they participate. Hence, we invite investigators to contribute research articles and review papers to the Journal of Enzymology and Metabolism that address these issues as well as papers which discuss the current advances made in understanding the role of potential biological response modifiers that could be proven to be central to designing effective treatments for these diseases.

 

In this issue, papers will be accepted covering the following general topics:

  1. The role of inflammatory pathways and their antagonists in CVD, diabetes, and cancer.
  2. The role of the receptors for advanced glycation end-products (RAGE) and oxidized lipoproteins in the pathogenesis of metabolic disorders, including obesity and diabetes
  3. The impact of inflammation-based clinical treatments for CVD, diabetes and cancer
  4. The role of enzymology in the identification of common metabolic links of these diseases